Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving Time of BCR::ABL1 IS Transcript Levels

OBJECTIVE: Achieving an early molecular response (EMR) is crucial for improving the prognosis of patients with chronic myeloid leukemia (CML). The halving time (HT) and reduction ratio (RR) of BCR::ABL1 transcript levels have recently emerged as additional prognostic indexes besides the BCR::ABL1 In...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceran, Funda, Akıncı, Sema, Uçar, Mehmet Ali, Korkmaz, Gülten, Gündüz, Mehmet, Çavdarlı, Büşranur, Bakanay, Şule Mine, Falay, Mesude, Dağdaş, Simten, Dilek, İmdat, Özet, Gülsüm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421336/
https://www.ncbi.nlm.nih.gov/pubmed/35620443
http://dx.doi.org/10.4274/tjh.galenos.2022.2022-0024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421336/
https://www.ncbi.nlm.nih.gov/pubmed/35620443
http://dx.doi.org/10.4274/tjh.galenos.2022.2022-0024

Ejemplares similares